These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21927372)

  • 1. Effect of imipramine and ect on platelet mao activity in depressives.
    Trivedi JK; Singh RP; Lal N; Viswanathan PN; Kumar S
    Indian J Psychiatry; 1989 Apr; 31(2):139-43. PubMed ID: 21927372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active platelet 5-ht uptake in depressives treated with impramine and ect.
    Dalal PK; Lal N; Trivedi JK; Seth PK; Agarwal AK; Khalid A
    Indian J Psychiatry; 1998 Jan; 40(1):60-6. PubMed ID: 21494445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet MAO deamination of serotonin in depressed patients. Changes after imipramine treatment and clinical correlations.
    Quintana J
    Biol Psychiatry; 1988 Jan; 23(1):44-52. PubMed ID: 3337854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood platelet monoamine oxidase activity in anergic schizophrenics.
    Shaskan EG; Becker RE
    Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):29-35. PubMed ID: 1233383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions.
    Schneider LS; Severson JA; Chui HC; Pollock VE; Sloane RB; Fredrickson ER
    Psychiatry Res; 1988 Sep; 25(3):311-22. PubMed ID: 2847206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet monoamine oxidase activity in schizophrenic patients.
    Becker RE; Shaskan EG
    Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased platelet 3H-imipramine binding and monoamine oxidase B activity in Alzheimer's disease.
    Bonuccelli U; Piccini P; Marazziti D; Cassano GB; Muratorio A
    J Neural Transm Park Dis Dement Sect; 1990; 2(2):139-47. PubMed ID: 2222781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet imipramine binding in endogenous depressed patients and controls: relationship to platelet MAO and 5HT uptake during successful imipramine treatment.
    Quintana J
    Psychiatry Res; 1990 Sep; 33(3):229-42. PubMed ID: 2173840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T; Aomine M
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123():13-26. PubMed ID: 25022028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T; Aomine M
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):13-26. PubMed ID: 22032088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo inhibition of platelet MAO activity by tricyclic antidepressants.
    Sullivan JL; Dackis C; Stanfield C
    Am J Psychiatry; 1977 Feb; 134(2):188-90. PubMed ID: 835743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria.
    Hannah P; Adams D; Glover V; Sandler M
    J Psychiatr Res; 1992 Jan; 26(1):69-75. PubMed ID: 1313874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase activity in different density gradient fractions of human platelets.
    Murphy DL; Costa JL; Shafer B; Corash L
    Psychopharmacology (Berl); 1978 Oct; 59(2):193-7. PubMed ID: 103122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chlorpromazine, imipramine and lithium on MAO-A and MAO-B activity in rat brain mitochondria.
    Nag M
    Indian J Exp Biol; 2004 Sep; 42(9):941-4. PubMed ID: 15462192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.
    van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
    J Clin Psychiatry; 2006 Feb; 67(2):263-8. PubMed ID: 16566622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of monoamine oxidase activity by various antidepressants: differences found in various mammalian species.
    Egashira T; Takayama F; Yamanaka Y
    Jpn J Pharmacol; 1999 Sep; 81(1):115-21. PubMed ID: 10580379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered platelet monoamine oxidase-B activity in idiopathic Parkinson's disease.
    Husain M; Shukla R; Dikshit M; Maheshwari PK; Nag D; Srimal RC; Seth PK; Khanna VK
    Neurochem Res; 2009 Aug; 34(8):1427-32. PubMed ID: 19259810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlations.
    Quintana J
    J Affect Disord; 1992 Feb; 24(2):55-62. PubMed ID: 1541767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression.
    Muck-Seler D; Sagud M; Mustapic M; Nedic G; Babic A; Mihaljevic Peles A; Jakovljevic M; Pivac N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1195-8. PubMed ID: 18423830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant drug therapy in psychotic depression.
    Davidson JR; McLeod MN; Kurland AA; White HL
    Br J Psychiatry; 1977 Nov; 131():493-6. PubMed ID: 338082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.